| Course | PSYC FPX 3310 Brain, Body, and Behavior |
|---|---|
| Assessment | Assessment 3 |
| Paper type | Disorder research brief |
| Length | About 1,120 words, 5 pages |
| Format | APA 7 student paper |
| School | Capella University |
| Program | BS in Psychology |
| Updated | September 2026 |
Free sample paper for PSYC FPX 3310 Assessment 3
Schizophrenia: A Disorder Research Brief That Defines the Condition by Current Criteria, Groups Findings by Method, States Replication Status for Each, Names What the Biology Does Not Explain, and Keeps a Clinical Register Without Advice
Student Name
Capella University
PSYC FPX 3310: Brain, Body, and Behavior
Instructor Name
Month Day, Year
The Condition Defined by Current Criteria
Schizophrenia is defined in the DSM-5-TR (American Psychiatric Association, 2022) by the presence of two or more characteristic symptoms, each present for a significant portion of time during a one-month period, at least one of which must be delusions, hallucinations, or disorganized speech. The remaining symptoms on the list are behavior that is grossly disorganized or catatonic, and negative symptoms, for example diminished emotional expression or reduced motivation. Functioning in areas such as work, relationships, or self-care must be markedly below the level achieved before onset, and continuous signs of the disturbance must persist for at least six months. Schizoaffective disorder and mood disorders with psychotic features must be ruled out, as must effects of substances or other medical conditions. Defining the condition this way matters because research findings depend on who was included: studies using older or broader definitions may include people who would not meet current criteria.
Findings Grouped by Method
Twin studies. Hilker et al. (2018) combined the Danish Twin Register and the Danish Psychiatric Research Register to study 31,524 twin pairs born between 1951 and 2000. The probandwise concordance rate, the probability that a twin of an affected person is also affected, was 33% for identical twins and 7% for fraternal twins. The estimated heritability of schizophrenia was 79%. Genome-wide association studies. The Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) compared the genomes of tens of thousands of people with schizophrenia with those of more than 100,000 people without it and identified 108 genetic loci associated with the disorder. Each locus contributes a very small increase in risk, and the associated genes include some involved in dopamine signaling and immune function. Structural imaging. Haijma et al. (2013) conducted a meta-analysis of brain volume studies including more than 18,000 participants. In medicated patients, total brain volume was about 2.6% smaller than in controls, and intracranial volume, which reflects early brain development, was about 2.0% smaller. The largest differences were in gray matter structures. Gray matter reduction was associated with longer illness and higher antipsychotic doses. Dopamine imaging. Howes et al. (2012) conducted a meta-analysis of imaging studies of the dopamine system. The largest abnormality was an elevation in presynaptic dopamine function, including dopamine synthesis capacity, with a large effect size of d = 0.79. There was a small elevation in D2 and D3 receptor availability, which was not found in patients who had never taken medication, and no change in dopamine transporter availability. Howes and Kapur (2009) proposed that dysregulated presynaptic dopamine is a final common pathway through which many risk factors lead to psychosis.
Replication Status Stated for Each
Twin heritability: well replicated. Hilker et al. (2018) described their estimate of 79% as congruent with earlier twin studies from other countries. Genome-wide associations: replicated and extended. The 108 loci were identified in a large combined sample, and the number of loci has grown in later, larger studies. Structural imaging: replicated across many studies, as the meta-analysis of more than 18,000 participants shows, though medication and illness duration complicate interpretation. Presynaptic dopamine elevation: replicated across the imaging studies in the meta-analysis by Howes et al. (2012), with a large effect; the smaller receptor findings were less consistent and depended on imaging approach. Even identical twins of people with schizophrenia were affected only a third of the time.
What the Biology Does Not Explain
The biological findings leave important questions unexplained. The concordance rate of 33% in identical twins, who share nearly all their genes, shows that genes alone do not determine who develops the disorder; Hilker et al. (2018) noted that this rate demonstrates that vulnerability is not solely genetic. Heritability estimates describe variation within the populations studied and do not identify the environmental factors that interact with genetic risk. The 108 loci each contribute very small effects and together explain only part of the genetic risk. Brain volume differences are small on average, overlap greatly between patients and controls, and are partly associated with medication, so they cannot be used to identify the disorder in an individual. The biology also leaves environmental risk largely outside its account. Twin concordance well below 100% points to factors that identical twins do not share, which may include events before birth, experiences in childhood, and exposures in adolescence. Research on such factors uses different methods, mainly epidemiological cohorts, and was not the focus of this brief, but its existence is implied by the biological findings themselves. A brief confined to biology should therefore say plainly that it describes one part of the causal picture, and that the part it describes cannot, on the evidence reviewed, be separated from the environments in which genetic and neural differences unfold. The dopamine findings describe a common pathway to psychotic symptoms but do not explain negative symptoms or cognitive difficulties, which respond poorly to medications that act on dopamine receptors. The biology also does not explain the course of the disorder, which varies widely across individuals.
Clinical Register, No Advice Given
This brief is written in a clinical register. It uses terms from the diagnostic criteria and the research literature, refers to people with schizophrenia rather than to schizophrenics, and describes symptoms and findings without dramatizing them. It does not offer advice about diagnosis, treatment, or what anyone should do if they or someone they know shows symptoms. Such advice would require clinical expertise and knowledge of an individual's situation, and a research brief reports what studies have found rather than how to act on it. The register also shapes how uncertainty is expressed. Findings are reported with their effect sizes and samples rather than with words such as proven or breakthrough, and associations are not described as causes. Where the research is incomplete, the brief says so directly. This restraint is part of the clinical register: it presents the evidence as a clinician or researcher would read it, with its strength and limits visible.
Conclusion
Schizophrenia, defined by current criteria as including at least two characteristic symptoms with at least one psychotic symptom, significant impairment, and a duration of at least six months, has substantial heritability, many genetic loci of small effect, small average reductions in brain volume, and elevated presynaptic dopamine function. These findings are well replicated, but identical twin concordance well below 100% and the limited explanatory reach of each finding show that biology alone does not account for the disorder.
References
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
Haijma, S. V., Van Haren, N., Cahn, W., Koolschijn, P. C. M. P., Hulshoff Pol, H. E., & Kahn, R. S. (2013). Brain volumes in schizophrenia: A meta-analysis in over 18 000 subjects. Schizophrenia Bulletin, 39(5), 1129-1138. https://doi.org/10.1093/schbul/sbs118
Hilker, R., Helenius, D., Fagerlund, B., Skytthe, A., Christensen, K., Werge, T. M., Nordentoft, M., & Glenthøj, B. (2018). Heritability of schizophrenia and schizophrenia spectrum based on the nationwide Danish twin register. Biological Psychiatry, 83(6), 492-498. https://doi.org/10.1016/j.biopsych.2017.08.017
Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III, the final common pathway. Schizophrenia Bulletin, 35(3), 549-562. https://doi.org/10.1093/schbul/sbp006
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012). The nature of dopamine dysfunction in schizophrenia and what this means for treatment: Meta-analysis of imaging studies. Archives of General Psychiatry, 69(8), 776-786. https://doi.org/10.1001/archgenpsychiatry.2012.169
Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427. https://doi.org/10.1038/nature13595
What the PSYC FPX 3310 Assessment 3 instructions ask for
The final assessment in PSYC FPX 3310 asks you to summarize biological research on a psychological disorder. You define the disorder using current diagnostic criteria, organize research findings by method, such as twin and genetic studies, neuroimaging and neurochemistry, report which findings have been replicated and which have not, identify what biological research has not yet explained and write in a clinical, non-stigmatizing tone. Treatment can be mentioned briefly where it connects to the biology, such as antipsychotic medications acting on dopamine receptors. Research from large genetic consortia, meta-analyses of brain structure and reviews of the dopamine hypothesis support the brief.
How this PSYC FPX 3310 Assessment 3 example is built
A brief is not an essay and the example keeps to the shorter form. It opens with the condition defined by current criteria and prevalence figures cited to a source, in a paragraph rather than a page. The evidence review that follows is grouped by kind of finding, structural, functional, neurochemical and genetic, because grouping by method lets the brief comment on the strength of each body of work rather than on individual papers. Inside each group the strongest and most replicated findings come first and the contested ones are labeled as contested. The evaluation section then states plainly how much of the condition this evidence explains, and answers the questions the biology has not resolved: why onset happens when it does, why course varies, and how much of the picture is environmental. A final paragraph names the study design the field still needs.
Reading the PSYC FPX 3310 Assessment 3 scoring guide
Marks go to the definition of the disorder, the organization by method, the reporting of replication status, the acknowledgment of gaps and the register of the writing. The definition reaches Distinguished when drawn from current DSM-5-TR criteria rather than popular descriptions. Organization scores higher when findings are grouped by method, so genetic, imaging and neurochemical evidence each have their own section. Replication status earns credit when stated for each finding, such as enlarged ventricles being well replicated while some single-gene findings have not held up. Gaps are judged on whether the paper names what biology does not yet explain, including why symptoms vary so much between people. The register should be clinical and respectful, using person-first language. Sources should be recent. Distinguished briefs are accurate and measured.
PSYC FPX 3310 Assessment 3 help: mistakes that cost marks
Disorder briefs often present biological findings as settled, although many early findings in schizophrenia research have not replicated. Another weakness is mixing methods together, so the reader cannot tell imaging results from genetic ones. Replication status is never mentioned. Gaps are ignored, suggesting that biology explains the whole disorder. Environmental factors, such as urban upbringing or cannabis use, are left out entirely. Stigmatizing words like "schizophrenics" appear. Sources are more than fifteen years old. Grouping findings under method headings with a short replication note for each keeps the brief accurate and closes the course with a clear view of what biology can and cannot yet explain.
Get a PSYC FPX 3310 Assessment 3 example written to your instructions
Put the Assessment 3 instructions and scoring guide from your PSYC FPX 3310 courseroom in front of us, with the condition your section assigned. The example is written to those criteria, findings grouped by method and the unexplained named, and reaches you within 24-48h. No charge applies to a first custom sample. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.
More PSYC FPX 3310 papers and BS in Psychology samples
- PSYC FPX 3310 Assessment 1: Structure and Function Paper
- PSYC FPX 3310 Assessment 2: Mechanism Analysis
- PSYC FPX 3501 Assessment 3: Evidence-based Recommendation Report
- PSYC FPX 3210 Assessment 3: Lifespan Synthesis Essay
- PSYC FPX 3520 Assessment 3: Persuasion Campaign Essay
- PSYC FPX 3130 Assessment 3: Policy Position Essay
PSYC FPX 3310 Assessment 3 questions, answered
Can I write about a condition I have?
Many sections allow it and some encourage it, but your own experience cannot appear as evidence about the condition in general. Keep the brief on the published research, avoid describing your own symptoms or treatment, and be aware that writing about material this close can make the neutral register harder to hold. If a different condition would be easier to keep cold, pick that one.
Should the brief cover treatment?
Only as evidence about mechanism, which is a real and useful role for it. That a drug acting on one system reduces symptoms tells you something about the biology, and briefs cite pharmacological work for exactly that reason. What the course rules out is recommending or evaluating treatment for a reader, since that is clinical advice and an undergraduate paper has no business offering it.
How recent do the sources have to be?
Recent enough that the diagnostic criteria match, which usually rules out work predating the current manual unless you are citing it as history. Imaging and genetic findings age quickly here, and a brief resting on a decade-old review will miss failed replications the field has since absorbed. Where a foundational study still stands, cite it and say why it still stands.
Where can I find a free PSYC FPX 3310 Assessment 3 sample paper?
The complete schizophrenia research brief is here, defining the condition by current criteria, grouping findings by method, stating replication status for each and naming what the biology does not explain.
Which sources are current enough for PSYC FPX 3310 Assessment 3?
Mostly from the last ten years for genetics and imaging, since those fields move quickly. Older landmark studies can be cited for history.